South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda. The PD-1 checkpoint inhibitor cancer treatment is fast becoming the ...

The order did not specify the rate that could be imposed, but used 25% as an example. The White House defended the post at first, calling to "stop the fake outrage", as members of both parties ...